Wells Fargo Downgrades Dimension Therapeutics (DMTX) to Market Perform Following Proposed Acquisition
Go back to Wells Fargo Downgrades Dimension Therapeutics (DMTX) to Market Perform Following Proposed Acquisition| Templeton Developing MarketsTrust Fund Class C (NASDAQ: DMTX) | Delayed: 5.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.95 | 52 Week High | $15.55 | |||
| Open | $2.55 | 52 Week Low | $4.00 | |||
| Day High | $5.95 | P/E | N/A | |||
| Day Low | $5.95 | EPS | $0.00 | |||
| Volume | 805 | |||||
